Outcomes Lab
How can we extend your life?
The Neuro-Oncology Outcomes Lab seeks to identify treatment procedures used both before and after surgery that improve patient care, quality of life, and mortality rates for patients with brain tumors. While the choice of treatment has the greatest affect on your life, be it surgery, radiation, or chemotherapy, it’s the little things that count when comes to better living; thriving vs. surviving.
Our Databases
Our work focuses specifically on:
Investigating the role of pre-hospital factors in determining access to neurosurgical care
Studying the impact of patient, provider, and hospital level factors in determining inpatient outcomes among brain tumor patients undergoing neurosurgical care
Assessing the role of pre-hospital, patient, provider, and hospital level factors on long-term patient survival
We study patients of all age groups, backgrounds, ethnicities, etc. that have brain tumors in order to produce well-rounded results that can apply to all future hospitals and patients. Some of the outside resources we use are the following:
Central Brain Tumor Registry of the United States Database
Surveillance Epidemiology and End Results Database
Medicare Database
SEER-Medicare Linked Database
Nationwide Inpatient Sample
Area Resource File
Prospective Databases
We are currently developing a multi-institutional, web-based database that will prospectively collect clinically relevant data on patients with brain tumors of all kinds. The database will contain pre-hospital variables, inpatient factors such as treatment procedures and pathological results, and long-term collected patient quality of life information. Our goals for this database are to:
Develop and validate quality of life tools for patients in all brain tumors subsets
Critically study the role of pre-hospital, patient, provider, hospital level, and quality of life factors on long-term patient survival
Retrospective Databases
We are currently focused on the study of different brain tumors through our 10-year institutional database. Looking back case allows us to compare cases and distinguish how specific factors impact a patient’s life after surgery. For each tumor type, we focus on the following target areas:
Defining appropriate inpatient and longitudinal outcome measures
Investigating test results and clinical factors predictive of doctor-patient or doctor-staff miscommunication and/or poor outcome
Investigating patient and operative factors contributing to morbidity and mortality around the time of surgery
Assessing the success of various surgical techniques and synthetic agents in the prevention of fluid leakage and organ tissue formation
Investigating laboratory parameters of endocrine disease predictive of response to surgical treatment (for pituitary tumors)
Investigating new testing/viewing measures to predict histological grade and overall survival (for low and high grade gliomas)
Studying histological characteristics predictive of tumor recurrence (for meningiomas)